Literature DB >> 24630617

Detailed evaluation of one step nucleic acid (OSNA) molecular assay for intra-operative diagnosis of sentinel lymph node metastasis and prediction of non-sentinel nodal involvement: experience from a London teaching hospital.

Shramana M Banerjee1, Nikolaos V Michalopoulos1, Norman R Williams2, Timothy Davidson1, Soha El Sheikh3, Nuala McDermott3, My-Anh Tran-Dang3, Stephen Davison3, Mohammed R Keshtgar4.   

Abstract

One step nucleic acid (OSNA) is a molecular diagnostic assay for intra-operative detection of sentinel node metastases. This study compared OSNA with standard histopathology in 283 nodes from 170 patients to evaluate sensitivity, specificity and concordance of the two methods. Additional analysis was done to investigate how cytokeratin 19 mRNA copy number affects prediction of non-sentinel node positivity. OSNA sensitivity was 93.2% and specificity 95.8%. Concordance between OSNA and histology was 95.6%. In the patients who had axillary clearance, the OSNA mRNA copy number on the sentinel node had 100% negative predictive value for histologically proven metastasis. mRNA copy numbers <1400 were not associated with histologically proven metastasis in subsequent nodes at axillary clearance. OSNA is a reliable method for the intra-operative evaluation of axillary lymph node metastasis even when half of the lymph node is used. Identification of mRNA copy number threshold predicting the positivity of non-sentinel axillary nodes seems to be feasible and would be clinically important.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Breast cancer; Cytokeratin 19 mRNA copy number; OSNA; One step nucleic acid; Sentinel lymph node biopsy

Mesh:

Substances:

Year:  2014        PMID: 24630617     DOI: 10.1016/j.breast.2014.02.001

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  5 in total

1.  Intraoperative prediction of non-sentinel lymph node metastases in breast cancer using cytokeratin 19 mRNA copy number: A retrospective analysis.

Authors:  Heloïse Pina; Julia Salleron; Pauline Gilson; Marie Husson; Marie Rouyer; Agnes Leroux; Philippe Rauch; Frederic Marchal; Mathilde Käppeli; Jean-Louis Merlin; Alexandre Harlé
Journal:  Mol Clin Oncol       Date:  2022-01-10

Review 2.  One-step nucleic acid amplification (OSNA): where do we go with it?

Authors:  Yasuhiro Tamaki
Journal:  Int J Clin Oncol       Date:  2016-08-22       Impact factor: 3.402

3.  Predicting of Sentinel Lymph Node Status in Breast Cancer Patients with Clinically Negative Nodes: A Validation Study.

Authors:  Annarita Fanizzi; Domenico Pomarico; Angelo Paradiso; Samantha Bove; Sergio Diotaiuti; Vittorio Didonna; Francesco Giotta; Daniele La Forgia; Agnese Latorre; Maria Irene Pastena; Pasquale Tamborra; Alfredo Zito; Vito Lorusso; Raffaella Massafra
Journal:  Cancers (Basel)       Date:  2021-01-19       Impact factor: 6.639

4.  Application of One-Step Nucleic Acid Amplification (OSNA) in different cancer entities and usefulness in prostate cancer: a systematic review.

Authors:  Enrique Trilla; Juan Morote; Mercè Cuadras; Jacques Planas; Ana Celma; Lucas Regis; Inés M de Torres; M Eugenia Semidey
Journal:  BMC Cancer       Date:  2022-04-02       Impact factor: 4.430

Review 5.  One-step nucleic acid amplification: the possible value in assessing sentinel lymph node metastasis during mastectomy.

Authors:  Alison E Hunter-Smith; Zenon Rayter
Journal:  Breast Cancer (Dove Med Press)       Date:  2018-01-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.